is saying, "You're not as 'powerful' as you think."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Two days ago you had him pegged as the next Tom Brady (read: GOD). Now, relinquished to the practice squad?
One more RS and I think I will then owe them shares. I suppose they could do another (if that's allowed and legal) if, lets say, share price being too low is some sort of a stumbling block to some entity wanting to sign on to financing this boat anchor.
I'm betting on the Non-Timely-10Q being next week as a NT-NT-10Q.
I think we may be able to consider this mid-August and maybe something (good) is happening in the background. Radio silence sucks.
0 shares traded so far today. Everyone must be waiting for that $60 share price before they jump in?
I cant believe I pay money for this.
I think instead he's going to dilute us up to that $5,000 per share price someone was talking about. The longer in the tooth this "financing" story gets the less likely I think it happens, in my opinion.
Personally, I wouldn't be surprised if we saw dilution.
I'm doubtful the trials have even begun yet.
Seriously? GTHP probably had to borrow money to file the 10Q as there was nothing in there earth shattering that they had to make it wait and have the stop sign put up on the OTC markets.
Meanwhile, back on planet Earth.....
Not for anything worthwhile, but there have literally been dozens of agreements with GTHP by others up that have also gone unfulfilled and unrealized. GTHP currently does not have the parts to complete machines, has no money to buy parts to complete the machines, fair for GTHP cannot even meet their own requirements to sell the machines. Let's try to keep stuff into perspective right now. This stock needs a financing agreement to pay for parts and labor tough start screwing these machines together. Financing is the key and it's the only key. A very wise friend of mine once said, "you can't produce anything if you don't have the money to do it".
Yes, Gene was clearly a layabout, doing nothing to enhance shareholder value. I made some phone calls to my imaginary friends Mark Zuckerberg and Jeffrey Immelt. They regretted to inform me that even though guided therapeutics was an easy win, and they could obviously get FDA approval first thing in the morning, they needed to go to the dentist and grab a few things from the grocery before they would entertain the fantastic offer of working for free. Stay tuned though.... I think I have them on the hook. I promised them free Dentyne gum for a month
One reply....
? What?
I like to compare My Joe and OTC'd.... Funny comparison! The sky is falling and the future is so bright everyone needs to put on some cheap sunglasses!
He won't take your bet. The F and I posts will continue beyond anyone's ability to tolerate them. His crap has kept me off here for like a month. Reading his posts make me want to stick a fork deep into my eye socket.
Macy the 10q before Wednesday
Ok, ok, so you lost a shitload of money.... Hold up your left hand and count how many people who actually care. There's one finger up. It's just you.
Well at least ICUFLM is different from "failed and incompetent". I'll give you a $25 to stop posting here. No wait, I'll give you $50 to stop posting here. Wife is sick of your s*** too. Said she'll pay $500 for you to stop posting here
Ridiculous. I'm hoping some sort of financing deal gets done so I can finally bail, and get on what's whatever I have with the remaining years of my life. I'm down 90% over 6 years and ready to die. Can't really stand reading the b******* pumper unrealistic crap. Gene needs to stop screwing around in England for the best deal and take anything he can get at this point to keep this POS alive.
Sorry that I've been away for awhile. Then I read this same old "failed and incompetent" remarks and I can't help myself to continue to watch those comments define a lack of experience, depth and imagination. Keep going... You're making a name for yourself!
You cannot find a better CEO for this flaming bag of dog crap that Gene has taken on has some sort of a personal vendetta to get this thing profitable. I don't get it either. I'd be happy to take the reigns and finish putting the wooden steak in the heart of this vampire stock if everyone will vote for that at the next shareholder's meeting? Come on! I can do it! Just like any other CEO worth his salt, I could just kill this company like everyone else would except for Gene, move on, Make some money before I retire and save my reputation.
GTHP currently a $hitshow, well, always been a $hitshow... Impo, financing announcement soon or continued, continued, continued getting screwed.
Interesting and curious at the same time.... Why hasn't the BOD fired this "F and I" CEO after these few short years if he is all that "F and I"? Why would this "F and I" CEO even make this announcement? Anyone with a clue knew all these things a month ago that Gene, the "F and I" CEO, put out today. Is funding at the end of August when the "tick-tock clock" is ticking for CH.7 at the end of July, folding for good, called here by someone, all while the "tick-tock clock" is ticking???? Weird at best. Could this PR be to get attention? Maybe Gene is job-hunting and needs to fill his resume? "Tick-tock, tick-tock, end-of-July" is rapidly approaching, end of "tick-tock July" just 7 weeks yet others who may or not be 'in-touch' with 'F-and-I" CEO state otherwise? Weird, at best. Maybe time to do that whole apartheid divesture thing, go to blue chips and abandon the MB? Not quite sure? Any opinions?
I don't want to wait for August again this year.
Glty, sir. I bought a ton (for me...) At $.045 and I'm happy as a new clam here.
Curious if while the wait is on to secure a financing agreement if Gene has managed to secure some temporary funding to keep the company afloat. Too many business partners have given up too much at this point to let the company die. If anyone has spoken to him lately please chime in here. A friend of mine who has an uncle who's granddaughter was a housekeeper for someone that was friends with someone that went to school with someone who's parents had a niece who was a worker at guided therapeutics who laid off I went to work somewhere else had a birthday.
It may be your time to sell my friend and salvage what scraps you can from your piggy bank. a friend of mine whose cousin was a housekeeper for someone that worked at guided therapeutics and passed Gene in the hall one time 3 years ago feels that the end is near in the company will fold by the end of July. The clock is ticking. Tick tock tick tock. End of July. And you called it here on this forum.
I just dipped my wick in today. Glad to be aboard and hope I'm not too late to the game.
Yes, GTHP has qualified and competent CEOs from around the globe from very successful medical device companies standing in a line with their resumes in hand right now! Each one screaming, "Pick me! Pick me! Pick me!" The line stretches around the corner! Yet, the board of directors doesn't pick any one of them to head up this company? Hmmmm. That makes me curious... Do you think Gene has something on the board of directors? Maybe it's some sort of an extortion situation? I'm sure glad about one thing. That I KNEW that this was a penny stock in the medical device industry before I bought MY shares. GLTY, sir!
Thank you for allowing me to answer in an extended retort of your aggressive query.
1. Although Gene hasn't had the ability to bring much value to shareholders, he could have thrown in the towel and folded GTHP leaving you and me and others at zero. Instead, he turned the focus on foreign markets for survival.
2. If Gene goes, do you actually think share price will rise? If so, I have 5,000 shares I'll let you have at a nice profit.
3. They could issue PR after PR with a lot of LOI's but you are smarter than that. A wise man once told me, "man with plan keep tight to his chest, man with none scream from the tree top".
4. FDA approval? Hello? Welcome to Earth, my name is Frank and typically, I would respond like "they have two chances, and if you don't like the first chance, you're certainly not going to like the second one." Let's try to focus on what's going on - foreign markets.
5. My "friend" has. . I have information that you don't. I haven't shared with you (and I won't LOL).
Gene has always been reachable, accessible and is willing to let us know what's happening. I've personally spoken to him as has my friend and multiple others on the board that email me back and forth. She thinks we will see big things in the next 2 months. I think it may be YOUR time to question the "FAILING and INCOMPETENT MANAGEMENT of GTHP" by calling Gene yourself.
TIP: have your questions ready, ask them, write his answers down, listen to what he says, ask follow-up questions, enjoy!
By the way, if Gene retires or moves on for a paycheck, we are screwed. That's you AND me, bud. Of course, everyone of us could move on, take our losses, lick the wound and learn a lesson, but NOOO! we stay here and whine and complain
Ok, but Gene really hasn't been in since Spectra, correct? Gene got in when the Co. was left as a flaming bag of hot dog $hit, going in unprepared for the FDA smackdown. I get the frustration, trust me. I know kids in some since the same time. Maybe it's time to duck out into RMLS and wait for a lift? At some point kids need to give up the GTHP dream, if they think Gene is not the guy to get it done. When Gene hangs it up, Mark Faupel likely takes ove
r. I bet you're familiar with him. If you don't think Gene can get it done with all his industry connections, think about Mark will or won't be able to get done and plan an exit strategy accordingly. I wish ALL in on GTHP the best, selfishly. GLTA!
How long you been in?
I was talking to someone recently who spoke to Gene, or so they claimed to.... According to the source, Gene seemed very excited about the prospects of the future. I'm not sure of all of the details as you can only believe so much after all these years of disappointments, but Gene told him that the financing deal would be done shortly. My source said it was in multiple millions of dollars of financing, not just one or two million. I've always referred to guided therapeutics as the Rodney Dangerfield of medical instrument companies. I'm being told it could turn into the Phyllis Diller or even Eddie Murphy of medical instrument companies in the very near future. Who sing as I've lost just about everything anyway, Hi might as well ride this SOB into the ground RCA 600% increase in share price by July 1st or sooner.
Well, I'll guess we will see. I mean, what's supporting this now? The 800 for 1? Nope. The lack of sales? Nope. The inability to fill any orders? Nope. Could it be that others have spoken with the CEO? Yep. Could it be that a financing deal is rapidly coming together? Yep. Could it be other things that don't appear on this message board or in any official announcements? Yep. But then again, maybe none of any of this is true. Guess we'll see. Others are buying, like I did again, can't understand why.... Good luck to you if you buy in, but keep watching...
The more I think about the debt reduction and toxic debt, the RS, the silence in announcements, and most importantly the small five figure loans over the past few months, the more interesting this becomes. Who on Gods green earth would lend the company ANY money AT ALL (especially at 6% ) unless they have either serious mental health issues or they know something that the rest of us don't? I figure very few people with serious mental health issues are walking around crazy enough to wager on GTHP. Therefor, THEY HAVE TO KNOW SOMETHING. I added today and have an order in for Monday. I think this is at rock bottom for now.
Didn't meet these financing 90 day deadlines, but are these folks confident that it is inevitable? Or is it pocket change at the nickel slots?
13. SUBSEQUENT EVENTS
On January 7, 2019 the Company entered into a promissory note for $25,000 with Richard Blumberg. The entire unpaid principal balance due on this Promissory Note (this "Note"), together with all accrued and unpaid interest and fees, if any, at the choice of Mr. Blumberg, shall be due and payable in full from the funds received by the Company from a financing of at least $1,000,000 or to be included as part of the Company's financing. Should the Company not complete a financing of at least $1,000,000 within 90 days of the execution of this Promissory Note, any unpaid amounts shall be due in full to the Mr. Blumberg and shall accrue 6% annual interest from the date thereof if not paid in full. In addition, Mr. Blumberg shall be granted ten common stock warrants for each dollar loaned to the Company under this Promissory Note, representing 313 warrants. The warrants shall vest upon the financing of at least $1,000,000 and expire on the third anniversary of said financing. The warrant exercise price shall be set at market price as defined by the five-day volume adjusted weighted price (VWAP), or alternatively the same as for warrants granted to investors as part of any $1 million dollar or more financing of the Company.
On January 17, 2019 the Company entered into a promissory note for $15,000 with Bryan Mamula. The entire unpaid principal balance due on this Promissory Note (this "Note"), together with all accrued and unpaid interest and fees, if any, at the choice of Mr. Mamula, shall be due and payable in full from the funds received by the Company from a financing of at least $1,000,000 or to be included as part of the Company's financing. Should the Company not complete a financing of at least $1,000,000 within 90 days of the execution of this Promissory Note, any unpaid amounts shall be due in full to Mr. Mamula and shall accrue 6% annual interest from the date thereof if not paid in full. In addition, Mr. Mamula shall be granted ten common stock warrants for each dollar loaned to the Company under this Promissory Note, representing 188 warrants. The warrants shall vest upon the financing of at least $1,000,000 and expire on the third anniversary of said financing. The warrant exercise price shall be set at market price as defined by the five-day volume adjusted weighted price (VWAP), or alternatively the same as for warrants granted to investors as part of any $1 million dollar or more financing of the Company.
On January 30, 2019 the Company entered into a promissory note for $35,000 with Richard Blumberg. The entire unpaid principal balance due on this Promissory Note (this "Note"), together with all accrued and unpaid interest and fees, if any, at the choice of Mr. Blumberg, shall be due and payable in full from the funds received by the Company from a financing of at least $1,000,000 or to be included as part of the Company's financing. Should the Company not complete a financing of at least $1,000,000 within 90 days of the execution of this Promissory Note, any unpaid amounts shall be due in full to Mr. Blumberg and shall accrue 6% annual interest from the date thereof if not paid in full. In addition, Mr. Blumberg shall be granted ten common stock warrants for each dollar loaned to the Company under this Promissory Note, representing 438 warrants. The warrants shall vest upon the financing of at least $1,000,000 and expire on the third anniversary of said financing. The warrant exercise price shall be set at market price as defined by the five-day volume adjusted weighted price (VWAP), or alternatively the same as for warrants granted to investors as part of any $1 million dollar or more financing of the Company.
69
On February 14, 2019, the Company entered into a Purchase and Sale Agreement with Everest Business Funding for the sale of its accounts receivable. The transaction provided the Company with $48,735 after $1,265 in bank costs for a total purchase amount of $50,000, in which the Company would have to repay $68,500. At a minimum the Company would need to pay $535.16 per day or 20.0% of the future collected accounts receivable or “receipts.”
On February 8, 2019, a note payable in default as reported in Footnote 9: Notes payable – Note payable in default, was exchanged for a note with a convertible option. The note amount was for $145,544. At the sole discretion of the Company, rather than paying the holder in cash, the note can be exchanged for equity in the new financing of at least $1,000,000. The debt will be exchanged for C3 preferred shares. If the Company elects to pay the balance in cash, the note shall accrue simple interest of 6% per annum commencing on the date of the new financing of at least $1,000,000.
On February 15, 2019 the Company entered into a promissory note for $50,000 with John Gould. The entire unpaid principal balance due on this Promissory Note (this "Note"), together with all accrued and unpaid interest and fees, if any, at the choice of Mr. Gould, shall be due and payable in full from the funds received by the Company from a financing of at least $1,000,000 or to be included as part of the Company's financing. Should the Company not complete a financing of at least $1,000,000 within 90 days of the execution of this Promissory Note, any unpaid amounts shall be due in full to the Mr. Gould and shall accrue 6% annual interest from the date thereof if not paid in full. In addition, Mr. Gould shall be granted ten common stock warrants for each dollar loaned to the Company under this Promissory Note, representing 625 warrants. The warrants shall vest upon the financing of at least $1,000,000 and expire on the third anniversary of said financing. The warrant exercise price shall be set at market price as defined by the five-day volume adjusted weighted price (VWAP), or alternatively the same as for warrants granted to investors as part of any $1 million dollar or more financing of the Company.
During March 2019, the Company entered into promissory notes for $46,000 with Richard Blumberg. The entire unpaid principal balance due on this Promissory Note (this "Note"), together with all accrued and unpaid interest and fees, if any, at the choice of Mr. Blumberg, shall be due and payable in full from the funds received by the Company from a financing of at least $1,000,000 or to be included as part of the Company's financing. Should the Company not complete a financing of at least $1,000,000 within 90 days of the execution of this Promissory Note, any unpaid amounts shall be due in full to the Mr. Gould and shall accrue 6% annual interest from the date thereof if not paid in full.
On March 29, 2019, the Company entered into a securities purchase agreement with Auctus Fund, LLC for the issuance and sale to Auctus of $65,000 in aggregate principal amount of a 12% convertible promissory note. On March 29, 2019, the Company issued the note to Auctus. Pursuant to the purchase agreement, the Company also issued to Auctus a warrant exercisable to purchase an aggregate of 325,000 shares of the Company’s common stock. The warrant is exercisable at any time, at an exercise price per share equal to $0.176 (110% of the closing price of the common stock on the day prior to issuance), subject to certain customary adjustments and price-protection provisions contained in the warrant. The warrant has a five-year term. The note matures nine months from the date of issuance and accrues interest at a rate of 12% per year. The Company could have prepaid the note, in whole or in part, for 115% of outstanding principal and interest until 30 days from issuance, for 125% of outstanding principal and interest at any time from 31 to 60 days from issuance, and for 130% of outstanding principal and interest at any time from 61 days from issuance to 180 days from issuance. After nine months from the date of issuance, Auctus may convert the note, at any time, in whole or in part, into shares of the Company’s common stock, at a conversion price equal to the lower of the price offered in the Company’s next public offering or a 40% discount to the average of the two lowest trading prices of the common stock during the 20 trading days prior to the conversion, subject to certain customary adjustments and price-protection provisions contained in the note. The note includes customary events of default provisions and a default interest rate of 24% per year. Upon the occurrence of an event of default, Auctus may require the Company to redeem the note (or convert it into shares of common stock) at 150% of the outstanding principal balance plus accrued and unpaid interest.
On April 16, 2019, the Company entered into a promissory note for $20,000 with Richard Blumberg. The entire unpaid principal balance due on this Promissory Note (this "Note"), together with all accrued and unpaid interest and fees, if any, at the choice of Mr. Blumberg, shall be due and payable in full from the funds received by the Company from a financing of at least $1,000,000 or to be included as part of the Company's financing. Should the Company not complete a financing of at least $1,000,000 within 90 days of the execution of this Promissory Note, any unpaid amounts shall be due in full to the Mr. Blumberg and shall accrue 6% annual interest from the date thereof if not paid in full.
70
On April 26, 2019, the Company entered into a promissory note for $50,000 with Fred Grimm. The entire unpaid principal balance due on this Promissory Note (this "Note"), together with all accrued and unpaid interest and fees, if any, at the choice of Mr. Grimm, shall be due and payable in full from the funds received by the Company from a financing of at least $1,000,000 or to be included as part of the Company's financing. Should the Company not complete a financing of at least $1,000,000 within 90 days of the execution of this Promissory Note, any unpaid amounts shall be due in full to the Mr. Grimm and shall accrue 6% annual interest from the date thereof if not paid in full. If upon financing Mr. Grimm decides to exchange any amount remaining under this promissory note into equity as part of the Company’s financing, Mr. Grimm shall receive a minimum of two common shares of the Company’s common stock and warrants to purchase two additional common stock shares of the Company’s common stock. In addition, Mr. Grimm shall be granted four common stock shares and four common stock warrants for each dollar loaned to the Company under this Promissory Note, representing 200,000 warrants. The warrants shall vest upon the financing of at least $1,000,000 and expire on the third anniversary of said financing. The warrant exercise price shall be set at market price as defined by the five-day volume adjusted weighted price (VWAP), or alternatively the same as for warrants granted to investors as part of any $1 million dollar or more financing of the Company.
Once the 10-K NTNTNT is filed and sent to Edgar,
1. How Fast is Edgar (FastEdgar) at getting them out?
2. Does anyone have any info on that?
3. How fast does the Stop sign get run over so the new kids waiting in the wings can get onboard and really launch this share price?
Thank you for any info you can provide and GO GTHP!
When the stop sign drops I'm in on this SOB!
I know we're all waiting with bated breath but I hope we're not setting ourselves up for a major disappointment. GTHP is not going to be showing any sales, any income, etc. We're all just hoping for that financing deal, aren't we....
….weeping from the outside, Glad you kids are riding the wave! Wish I was with you on this one...…